Understanding Your Biomarker Test Report Colorectal Cancer Alliance • understand the results of a biomarker test report • recognize how identifying key biomarkers can affect treatment decisions • identify potential therapy options based on test results • define a basic strategy for selecting a clinical trial • develop a list of key questions to ask your healthcare provider. If your biomarker testing reveals that your tumor has certain biomarkers, your doctor can choose treatments that are targeted to that specific type of colorectal cancer. biomarker testing can also determine which treatments to avoid, since some cancers do not respond well to certain therapies.
Understanding Your Biomarker Test Report Colorectal Cancer Alliance Biomarker testing is a way to look for genes, proteins, and other substances (called biomarkers or tumor markers) that can provide information about cancer. each person’s cancer has a unique pattern of biomarkers. some biomarkers affect how certain cancer treatments work. What do the results of a biomarker test mean? you might get different types of results from biomarker testing. the results might show. that your cancer has a certain biomarker that is targeted by a known treatment, so this might be an option to help treat your cancer. Biomarker testing identifies the alterations in your tumor cells that is causing them to grow abnormally. the oncoextra® test provides detections of the biomarkers in your tumor, as well as the treatment options that may be most appropriate for you. ntrk3, ret, braf, alk, egfr, erbb2, kras, met, ros1, pd l1. Step 4: identifying biomarkers. we sometimes look for biomarkers because these can help physicians provide eligible patients with individualized — or targeted — therapies. this is particularly true for patients who have been diagnosed with breast cancer or lung cancer. but biomarkers are also present in several other types of tumors.
Biomarker Analysis B Neuro Immuno Histochemistry Simple Western Biomarker testing identifies the alterations in your tumor cells that is causing them to grow abnormally. the oncoextra® test provides detections of the biomarkers in your tumor, as well as the treatment options that may be most appropriate for you. ntrk3, ret, braf, alk, egfr, erbb2, kras, met, ros1, pd l1. Step 4: identifying biomarkers. we sometimes look for biomarkers because these can help physicians provide eligible patients with individualized — or targeted — therapies. this is particularly true for patients who have been diagnosed with breast cancer or lung cancer. but biomarkers are also present in several other types of tumors. Your oncoextra test results can help you and your doctor better understand your disease, so that together you can make decisions about how to treat your cancer. the report gives your doctor three important insights that can help inform your treatment choice:. Has my cancer been tested for all treatable biomarkers and biomarkers for clinical trials? based would on my more tests results, offer more how do we treatment decide if a options? treatment or clinical trial is right for me? let’s discuss the approved and available treatment options. Clinical utility: if the answer is “biomarker test” – what’s the question? addresses the question "will it change the treatment approach?" how useful are test results to the person tested. may depend on effective access to appropriate interventions and an individual’s willingness to adopt the recommended interventions. Biomarker test results are crucial for lung cancer patients to understand. but they are difficult to read due to their complexity.